What are the opportunities and challenges of China healthcare reform?

Patients, practitioners and pharmaceutical companies should get ready for more changes as Beijing shows no signs of slowing down efforts to reform China’s healthcare system. What are the policy considerations driving the new reforms? How will negotiations for the national reimbursement drug list change? What next for group purchasing organizations? Dr. Bin Jiang, Associate Professor at Peking University, will share his insights on China’s evolving healthcare system.